JUSTIN MYNATT: Open Payments
NPI 1215371299 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,553 in 72 payments from 14 companies in 2025. Trend: 2023 $4,193 · 2024 $585 · 2025 $2,553
Food & beverage: $1,489Consulting: $833Travel & lodging: $231
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $1,420 |
| Janssen Pharmaceuticals, Inc | 17 | $211 |
| Vanda Pharmaceuticals Inc. | 4 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $120 |
| Alkermes, Inc. | 5 | $106 |
| Teva Pharmaceuticals USA, Inc. | 4 | $101 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Neurocrine BioSciences, Inc. | 3 | $74 |
| Corium, LLC | 3 | $74 |
Products named: COBENFY, INVEGA SUSTENNA, CAPLYTA, FANAPT, ARISTADA, UZEDY, Auvelity, INGREZZA.
Industry payments across TN — which companies pay providers there.
